Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
9.76
+0.89 (10.03%)
At close: Nov 24, 2025, 4:00 PM EST
9.71
-0.05 (-0.51%)
Pre-market: Nov 25, 2025, 7:50 AM EST
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
691.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OMER News
- 7 days ago - Omeros Corporation (OMER) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Omeros Corporation Reports Third Quarter 2025 Financial Results - Business Wire
- 13 days ago - Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025 - Business Wire
- 5 weeks ago - Omeros: Novo Nordisk Deal Highlights MASP-3 Alternative Pathway Targeting - Seeking Alpha
- 5 weeks ago - Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case - Seeking Alpha
- 5 weeks ago - Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group - Business Wire
- 5 weeks ago - Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal - Benzinga
- 5 weeks ago - Can OMER stock retain Novo Nordisk driven gains over the long-term? - Invezz